跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 39,192 条关于
“Shanghai Pharmaceutical Group”
全部
39,192
临床试验
18,703
药物
2,506
机构
2,670
资讯
15,313
去年
Fosun Pharma's Innovative Drug Receives Registration Acceptance in China
去年
Novartis Expands Strategic Partnership with Shanghai Pharma to Accelerate Ophthalmic Drug Distribution in China
去年
Henlius Biotech in Advanced Licensing Talks with J&J and Roche for Experimental Cancer Drug
10天前
Accro Bioscience Announces NMPA Clearance for Phase II/III Trial of AC-201, a Selective TYK2/JAK1 Inhibitor for Non-Segmental Vitiligo
9个月前
HER2-Negative Breast Cancer Pipeline Expands with 75+ Therapies from 70+ Companies
9个月前
Pfizer Secures Exclusive Rights to YaoPharma's Oral GLP-1 Agonist YP05002 in $2.1 Billion Deal
去年
Teva and Fosun Pharma Form Strategic Partnership for Novel Anti-PD1-IL2 Cancer Immunotherapy TEV-56278
5个月前
Tortugas Neuroscience Emerges from Stealth with $106M to Advance CNS Drug Pipeline Licensed from Eisai and Hansoh
4个月前
Arcera Life Sciences and Fosun Pharma Form Strategic Partnership to Bridge Chinese Innovation with Global Markets
去年
RAPT Therapeutics Licenses Novel Anti-IgE Antibody RPT904 for Global Development
第 1 页，共 1532 页
上一页
下一页
